The C-suite cluster sale is not a bearish signal given the trivial dollar amount relative to market cap and the simultaneous timing across all four executives. This pattern is consistent with a routine 10b5-1 plan or post-blackout-window opening. Monitor the next 8-K or earnings release for any material business update that could have prompted the sales, but the current data does not suggest a negative read-through.
Price Chart
Executive Summary
Five Oruka Therapeutics insiders, including the CEO, CMO, COO, General Counsel, and SVP Finance, sold a total of $396K in open-market shares over a 7-day window. The CEO sold $120K at $69.69, the CMO sold $112K at $68.38, and the COO sold $42K at $69.69. The cluster is notable for involving the entire C-suite (CEO, CMO, COO) plus the General Counsel and finance head, but the total dollar value is only ~0.009% of the $4.4B market cap — well below the 0.1% threshold for materiality. The sales appear to be routine, likely driven by shared blackout-window opening or 10b5-1 plan timing, not a coordinated bearish signal.
Key Financial Metrics
Key Facts
- Five insiders sold open-market shares totaling $396K from June 15-22, 2026
- CEO Paul Klein sold 1,700 shares at $69.69 for $120K
- CMO Joana Goncalves sold 1,600 shares at $68.38 for $112K
- COO Laura Lee Sandler sold 600 shares at $69.69 for $42K
- General Counsel Paul Quinlan sold 733 shares at $69.69 for $51K
- SVP Finance Arjun Agarwal sold 888 shares at $80.01 for $71K on June 22
- Total sales represent ~0.009% of the $4.4B market cap — trivial in proportion
- All C-suite sales occurred on the same date (June 15), suggesting a shared blackout-window or 10b5-1 plan opening
Financial Impact
Total insider sales of $396K, or ~0.009% of market cap — immaterial
Risk Factors
- Insider sales at this scale are not predictive of stock movement; the cluster is noise
- The stock has a 95% analyst buy rating and strong institutional backing (Fidelity, BlackRock, RTW) — the selling is not aligned with the Street's bullish view
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ORKA-1782172805450 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 16d ago | Insider Cluster | $93.55 $89.93 | ▼ −3.87% | ▼ −6.44% | $84.38 (−9.80%) |
Sep 1, 2026 4w ago | Insider Cluster | $91.63 $91.65 | ▼ −0.02% | ▼ −0.98% | $84.38 (+7.91%) |
Aug 28, 2026 5w ago | EFFECT | $91.15 $92.51 | ▼ −1.50% | ▼ −1.39% | $84.38 (+7.42%) |
Aug 17, 2026 6w ago | Insider Cluster | $113.08 $101.82 | ▼ −9.96% | ▼ −9.76% | $84.38 (−25.38%) |
Aug 10, 2026 7w ago | Press Release | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | $84.38 (−19.75%) |
Aug 10, 2026 7w ago | 8-K | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | $84.38 (−19.75%) |
Aug 9, 2026 7w ago | Institutional Cluster | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | $84.38 (−19.75%) |
Jul 15, 2026 11w ago | Insider Cluster | $83.04 $91.95 | ▲ +10.73% | ▲ +12.40% | $84.38 (+1.61%) |
Jul 2, 2026 13w ago | Insider Cluster | $85.21 $88.27 | ▲ +3.59% | ▲ +2.66% | $84.38 (−0.97%) |
Jun 22, 2026 14w ago | Insider Cluster | $83.40 $92.49 | ▲ +10.90% | ▲ +9.89% | $84.38 (+1.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access